Luciano Levato Selected Research

Luciano Levato Research Topics

18	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2023 - 01/2011
14	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2022 - 02/2009
6	Neoplasms (Cancer) 11/2021 - 04/2012
3	Infections 05/2023 - 06/2021
3	Residual Neoplasm 01/2023 - 01/2020
2	COVID-19 05/2023 - 01/2022
2	Leukemia 12/2019 - 01/2015
2	Anemia 04/2018 - 01/2011
1	Peripheral Nervous System Diseases (PNS Diseases) 11/2021
1	Acute Promyelocytic Leukemia 11/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 06/2021
1	Atrial Fibrillation 03/2021
1	Hematologic Diseases (Blood Diseases) 12/2019
1	Primary Myelofibrosis (Myelosclerosis) 04/2018
1	Fatigue 01/2018
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2018
1	Philadelphia Chromosome 08/2017
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 01/2016
1	Thrombosis (Thrombus) 09/2015
1	Chromosome Aberrations (Chromosome Abnormalities) 03/2015
1	Lymphocytosis 03/2015
1	Peripheral Arterial Occlusive Disease 1 06/2013
1	Hematologic Neoplasms (Hematological Malignancy) 04/2012
1	Disease Progression 04/2012
1	Leukostasis 09/2011
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 09/2011
1	Pancreatitis 12/2009
1	Pathologic Complete Response 02/2009

9	Tyrosine Kinase InhibitorsIBA 01/2022 - 02/2009
8	Imatinib Mesylate (Gleevec)FDA Link 08/2017 - 02/2009
7	nilotinib FDA Link 10/2022 - 12/2009
6	ibrutinibIBA 01/2022 - 01/2016
2	COVID-19 VaccinesIBA 05/2023 - 01/2022
2	Rituximab (Mabthera)FDA Link 01/2023 - 01/2018
2	venetoclaxIBA 01/2023 - 06/2021
2	Proteins (Proteins, Gene)FDA Link 03/2015 - 01/2015
1	VaccinesIBA 05/2023
1	ribonucleotide polymeraseIBA 01/2023
1	BNT162 VaccineIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 11/2021
1	Arsenic Trioxide (Trisenox)FDA Link 11/2021
1	Dabigatran FDA Link 03/2021
1	AnticoagulantsIBA 03/2021
1	Glucose (Dextrose)FDA LinkGeneric 11/2020
1	Chlorambucil (Leukeran)FDA Link 01/2020
1	obinutuzumabIBA 01/2020
1	Antiviral Agents (Antivirals)IBA 11/2018
1	ruxolitinibIBA 04/2018
1	Deferasirox FDA Link 04/2018
1	Monoclonal AntibodiesIBA 01/2018
1	CD20 AntigensIBA 01/2018
1	Thymidine KinaseIBA 01/2016
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 03/2015
1	Biomarkers (Surrogate Marker)IBA 07/2014
1	Vitamin D FDA LinkGeneric 04/2012
1	hydroxide ionIBA 04/2012
1	Hemoglobins (Hemoglobin)IBA 01/2011
1	HematinicsIBA 01/2011
1	Lipase (Acid Lipase)FDA Link 12/2009

14	Therapeutics 01/2022 - 02/2009
4	Drug Therapy (Chemotherapy) 11/2021 - 01/2011
1	Blood Transfusion (Blood Transfusions) 01/2011